Bioequivalence Study of Gabapentin 400 mg Capsules Under Fasting Conditions
NCT00778271 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2008-10-23
Summary
The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Parke-Davis (Neurontin®) 400 mg Gabapentin, following administration of a 400 mg dose under fasting conditions
Conditions
- Healthy
Interventions
- DRUG
-
Gabapentin 400mg capsules
Sponsors & Collaborators
-
Ranbaxy Laboratories Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-09-30
- Primary Completion
- 2002-10-31
- Completion
- 2002-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Gabapentin From Nerpentin 600 mg (Test ) F.C.T (Aman Pharma ,Egypt.) and Gabapentin From Neurontin 300 mg (Referance ) H.G.C. ( Pfizer Egypt)
NCT04805827 ·Status: COMPLETED ·Phase: NA
-
Levetiracetam 750 mg Tablets Under Non-Fasting Conditions
NCT00849485 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Two-Way Crossover Fasted Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers
NCT00864968 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions
NCT00616681 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence Study of Topiramate Tablets 25mg Under Fed Conditions
NCT00902473 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions
NCT00951600 ·Status: COMPLETED ·Phase: NA
-
Relative Bioavailability of 2 Oral Formulations of Nintedanib
NCT02572752 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition
NCT01513720 ·Status: COMPLETED ·Phase: PHASE1
-
Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions
NCT00849797 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers
NCT00864604 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions
NCT00759902 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed Condition
NCT00951847 ·Status: COMPLETED ·Phase: NA
-
Topiramate 25 mg Capsules Under Fed Conditions
NCT00904943 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.
NCT04390776 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
NCT00616863 ·Status: COMPLETED ·Phase: NA
-
Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
NCT00618046 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed Conditions
NCT00759915 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Evaluate Bioequivalence of LCB01-0371 in Different Batches
NCT04939779 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of KBP-5074 Tablet vs Capsule Formulations
NCT03340753 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Two Different Capsule Types of Dabigatran
NCT01290757 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions
NCT01581788 ·Status: COMPLETED ·Phase: PHASE1
-
Lamotrigine 25 mg Chewable Tablets, Fasting
NCT00838279 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions
NCT00834561 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study Comparing Two Different Tafamidis Formulations
NCT02217813 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability and Bioequivalence of Opicapone
NCT03820037 ·Status: COMPLETED ·Phase: PHASE1